Page last updated: 2024-08-24

coomassie brilliant blue and n-methyl-3,4-methylenedioxyamphetamine

coomassie brilliant blue has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Borcel, E; Colado, MI; Gutierrez-Lopez, MD; O'Shea, E; Perez-Hernandez, M; Porcu, F; Rubio-Araiz, A; Urrutia, A	1

Other Studies

1 other study(ies) available for coomassie brilliant blue and n-methyl-3,4-methylenedioxyamphetamine

Article	Year
3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) disrupts blood-brain barrier integrity through a mechanism involving P2X7 receptors. The international journal of neuropsychopharmacology, 2014, Volume: 17, Issue:8 Topics: Animals; Blood-Brain Barrier; Body Temperature; Collagen Type IV; Dentate Gyrus; Hippocampus; Immunoglobulin G; Laminin; Male; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; Microglia; N-Methyl-3,4-methylenedioxyamphetamine; Purinergic P2X Receptor Agonists; Purinergic P2X Receptor Antagonists; Pyridines; Rats; Receptors, Purinergic P2X7; Rosaniline Dyes; Tetrazoles	2014

Article

Year

3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) disrupts blood-brain barrier integrity through a mechanism involving P2X7 receptors.

The international journal of neuropsychopharmacology, 2014, Volume: 17, Issue:8

Topics: Animals; Blood-Brain Barrier; Body Temperature; Collagen Type IV; Dentate Gyrus; Hippocampus; Immunoglobulin G; Laminin; Male; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; Microglia; N-Methyl-3,4-methylenedioxyamphetamine; Purinergic P2X Receptor Agonists; Purinergic P2X Receptor Antagonists; Pyridines; Rats; Receptors, Purinergic P2X7; Rosaniline Dyes; Tetrazoles

2014